Literature DB >> 184986

Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation.

P S Bachorik, P D Wood, J J Albers, P Steiner, M Dempsey, K Kuba, R Warnick, L Karlsson.   

Abstract

The widely used heparin/MnCl2 precipitation procedure for determination of plasma high-density lipoprotein cholesterol has been re-examined in light of recent reports that isolated preparations of the lipoprotein are only partly precipitated under the test conditions. In the present study, the procedure as applied to plasma tolerated rather wide variations in heparin and MnCl2 concentrations without significant effects on the assayed values in several plasma pools tested. The procedure was further tested on 129 individual samples by comparison with an ultracentrifugal method in which high-density lipoprotein-cholesterol is assumed to be represented by the cholesterol content of the plasma fraction of relative (to water) density greater than 1.063. Our results indicate that high-density lipoprotein is not precipitated under the test conditions when applied to unfractionated plasma.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184986

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

2.  Plasma lecithin: cholesterol acyltransferase activity in liver disease.

Authors:  K Horii; Y Adachi; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1979-12

3.  alpha-Tocopherol and serum lipoproteins.

Authors:  G S Sundaram; R London; S Manimekalai; P P Nair; P Goldstein
Journal:  Lipids       Date:  1981-04       Impact factor: 1.880

4.  Effect of brominated vegetable oils on heart lipid metabolism.

Authors:  Y B Lombardo; A Chicco; M Z Basílico; C Bernal; R Gutman
Journal:  Lipids       Date:  1985-07       Impact factor: 1.880

5.  The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health.

Authors:  Julius Oben; Ebangha Enonchong; Dieudonne Kuate; Dora Mbanya; Tiffany C Thomas; DeWall J Hildreth; Thomas D Ingolia; Michael S Tempesta
Journal:  Lipids Health Dis       Date:  2007-09-05       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.